INVESTORS | J. Molner

top of page

picture of a chemistry laboratory

INVESTORS

STOCK EXCHANGE RELEASES

5 May. 2025 Notice of J. Molner AS Regarding the Adoption of a Shareholders' Resolution Without Convening a General Meeting

25 Apr. 2025 Option Agreement Signed with Key Employee

21 Apr. 2025 J. Molner AS Audited Consolidated Annual Report 2024

28 Mar. 2025 J. Molner AS 2024 12 months consolidated unaudited interim report

PRESS RELEASES

7 Nov. 2022 Pharmaceutical company J. Molner raised about 700,000 euros in the IPO

27 Oct. 2022 J. Molner Introduction Webinar (English)

19 Oct. 2022 IPO of the pharmaceutical company Molner commences on 24 October

06 Oct. 2022 J. Molner submits first drug to Health Canada

KEY DOCUMENTS

J. Molner AS Consolidated Annual Report 2024

J. Molner AS Consolidated Annual Report 2024

Annual Meeting of Shareholders 2025

Report of the Supervisory Board Regarding Financial Year 2024

Supervisory Board Resolution

J. Molner AS Consolidated Annual Report 2024

J. Molner AS Annual General Meeting of Shareholders Management Board Resolution 2024 (EE)

J.Molner AS annual general meeting electronic voting form 2024

J.Molner AS annual general meeting power of attorney form 2024

J. Molner AS Consolidated Annual Report 2023

J. Molner AS Consolidated Annual Report 2023

Annual Meeting of Shareholders 2024

Report of the Supervisory Board Regarding Financial Year 2023

Supervisory Board Resolution

J. Molner AS Consolidated Annual Report 2023

J. Molner AS annual general meeting of shareholders management board resolution 2023 (EE)

J.Molner AS annual general meeting electronic voting form 2023

J.Molner AS annual general meeting power of attorney form 2023

J. Molner AS voting protocol of shareholders' decisions

FIRESIDE CHAT - 3 NOV 2022

live from the EBS studio, a conversation with our founder

WEBINAR - 27 OCT 2022

bottom of page